市場調査レポート

商品コード

北米の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

North America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日: 2024年01月05日 | 発行: The Insight Partners

| ページ情報: 英文 125 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,550 556,107円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,550 712,757円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,550 869,407円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.65円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

北米の分子診断市場は、2022年の80億5,648万米ドルから2030年には207億4,038万米ドルに成長すると予測されています。2022年から2030年までのCAGRは12.5%と推定されます。

新製品の開拓とポイントオブケア検査需要の増加が北米の分子診断市場を活性化

ポイントオブケア検査は、分析範囲と臨床応用が急速に発展している医学の一分野です。ポイントオブケア検査ソリューションプロバイダーは、血糖測定から粘弾性凝固アッセイまで、さまざまな評価用の製品を提供しています。これらの検査は、臨床サンプルの輸送や調製の手間を省き、専門家がより短時間で追加検査や治療に関する臨床判断を下すことを可能にします。この新たなヘルスケアソリューションは、患者や医療サービス提供者に積極的に採用されています。ポイント・オブ・ケア検査は、治療、診断、患者モニタリングなどの用途で広く使用されています。さらに、ポイントオブケア製品やサービスは、在宅医療に対する患者の要望に応える上でヘルスケアプロバイダーに役立ちます。これらの製品やサービスは、COVID-19パンデミックの際に、患者が診断施設や治療施設に出向く代わりに自宅で検査を受けられるようにすることで、特に役立つことが証明されました。このように、ポイントオブケア検査に対する需要の高まりは、分子診断市場に利益をもたらしています。

北米の分子診断市場概要

北米の分子診断市場は米国、カナダ、メキシコに区分されます。先端技術製品の採用増加、研究開発活動の活発化、大手ヘルスケア企業の存在、分子診断の利用拡大などが、同地域の分子診断市場成長を後押しする主要因となっています。2022年の北米の分子診断市場は米国が最大シェアを占めました。

北米の分子診断市場の収益と2030年までの予測（金額）

北米の分子診断市場セグメンテーション

北米の分子診断市場は、疾患領域、技術、製品・サービス、エンドユーザー、国に区分されます。

疾患領域別に見ると、北米の分子診断市場は感染症、腫瘍、遺伝子検査、心疾患、免疫系疾患、その他に区分されます。感染症分野は2022年に北米の分子診断市場で最大のシェアを記録しました。

技術別では、北米の分子診断市場は、ポリメラーゼ連鎖反応（PCR）、in situハイブリダイゼーション、等温核酸増幅技術（INAAT）、DNAシーケンシングおよび次世代シーケンシング（NGS）、DNAマイクロアレイ、その他に区分されます。ポリメラーゼ連鎖反応（PCR）セグメントは、2022年に北米の分子診断市場で最大のシェアを記録しました。ポリメラーゼ連鎖反応（PCR）はさらにRT-PCR、qPCR、マルチプレックスPCR、その他に細分化されます。

製品とサービスに基づいて、北米の分子診断市場はアッセイとキット、機器、サービスとソフトウェアに区分されます。2022年の北米の分子診断市場シェアは、アッセイとキット分野が最大でした。

エンドユーザー別では、北米の分子診断市場は診断ラボ、病院・クリニック、研究・学術機関、その他に区分されます。2022年の北米の分子診断市場シェアは、診断ラボ部門が最大でした。

国別では、北米の分子診断市場は米国、カナダ、メキシコに分類されます。2022年の北米の分子診断市場は米国が支配的でした。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AG、TBG Diagnostics Limitedは北米の分子診断市場に参入している大手企業です。

List Of Tables

Table 1. North America Molecular Diagnostics Market Segmentation
Table 2. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 3. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 4. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 6. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 7. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 9. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 12. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 13. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 14. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. North America - PEST Analysis
Figure 2. North America Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Molecular Diagnostics Market, 2022 ($Mn)
Figure 33. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)

Product Code: TIPRE00026717

The North America molecular diagnostics market is expected to grow from US$ 8,056.48 million in 2022 to US$ 20,740.38 million by 2030. It is estimated to grow at a CAGR of 12.5% from 2022 to 2030.

Development of New Products and Increase in Demand for Point-of-Care Testing Fuels North America Molecular Diagnostics Market

Point-of-care testing is a branch of medicine with a rapidly evolving analytical scope and clinical application. Point-of-care testing solution providers offer products for various evaluations, ranging from blood glucose measurement to viscoelastic coagulation assays. Eliminating the time of transportation and preparation of clinical samples, these tests enable professionals to make clinical decisions about additional testing or therapy in less time. This emerging healthcare solution is being aggressively adopted by patients and healthcare service providers. Point-of-care assays are extensively used in therapeutics, diagnostics, and patient monitoring applications, among others. Moreover, point-of-care products and services help healthcare providers in meeting patients' demand for at-home medical care. These products and services proved specifically helpful during the COVID-19 pandemic by allowing patients to take tests from their homes instead of traveling to diagnostic or treatment facilities, thereby lowering the risk of infection. Thus, the rising demand for point-of-care testing benefits the molecular diagnostics market.

North America Molecular Diagnostics Market Overview

The North America molecular diagnostics market has been segmented into the US, Canada, and Mexico. The increasing adoption of technologically advanced products, rise in research & development activities, presence of large healthcare businesses, and growing use of molecular diagnostics are among the key factors propelling the growth of the molecular diagnostics market in this region. The US held the largest share of the North America molecular diagnostics market in 2022.

North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

North America Molecular Diagnostics Market Segmentation

The North America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the North America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest North America molecular diagnostics market share in 2022.

Based on technology, the North America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest North America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further subsegmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the North America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest North America molecular diagnostics market share in 2022.

Based on end users, the North America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest North America molecular diagnostics market share in 2022.

Based on country, the North America molecular diagnostics market has been categorized into the US, Canada, and Mexico. The US dominated the North America molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the North America molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis

5. North America Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - North America Market Analysis

6.1 North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Molecular Diagnostics Market - Country Analysis

11.1 North America Molecular Diagnostics Market, Revenue and Forecast To 2030
- 11.1.1 Overview
  - 11.1.1.1 North America Molecular Diagnostics Market, by Country
- 11.1.2 US
  - 11.1.2.1 Overview
- 11.1.3 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 US Molecular Diagnostics Market, by Disease Area
- 11.1.5 US Molecular Diagnostics Market, by Technology
  - 11.1.5.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
- 11.1.6 US Molecular Diagnostics Market, by Product and Services
- 11.1.7 US Molecular Diagnostics Market, by End User
- 11.1.8 Canada
  - 11.1.8.1 Overview
- 11.1.9 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Canada Molecular Diagnostics Market, by Disease Area
- 11.1.11 Canada Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Canada Molecular Diagnostics Market, by Product and Services
- 11.1.13 Canada Molecular Diagnostics Market, by End User
- 11.1.14 Mexico
  - 11.1.14.1 Overview
- 11.1.15 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 Mexico Molecular Diagnostics Market, by Disease Area
- 11.1.17 Mexico Molecular Diagnostics Market, by Technology
  - 11.1.17.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 Mexico Molecular Diagnostics Market, by Product and Services
- 11.1.19 Mexico Molecular Diagnostics Market, by End User

12. North America Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. North America Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Qiagen NV
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 bioMerieux SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novartis AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 TBG Diagnostics Limited
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

北米の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

North America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章北米の分子診断市場情勢

第5章北米の分子診断市場-主要産業力学

第6章分子診断市場-北米市場分析

第7章北米の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章北米の分子診断市場：収益と2030年までの予測 - 技術別

第9章北米の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章北米の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章北米の分子診断市場：国別分析

第12章北米の分子診断市場の業界情勢

第13章北米の分子診断市場、主要企業プロファイル

第14章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. North America Molecular Diagnostics Market Landscape

5. North America Molecular Diagnostics Market - Key Industry Dynamics

6. Molecular Diagnostics Market - North America Market Analysis

7. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

8. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

10. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. North America Molecular Diagnostics Market - Country Analysis

12. North America Molecular Diagnostics Market Industry Landscape

13. North America Molecular Diagnostics Market, Key Company Profiles

14. Appendix

北米の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

North America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 北米の分子診断市場情勢

第5章 北米の分子診断市場-主要産業力学

第6章 分子診断市場-北米市場分析

第7章 北米の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章 北米の分子診断市場：収益と2030年までの予測 - 技術別

第9章 北米の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章 北米の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章 北米の分子診断市場：国別分析

第12章 北米の分子診断市場の業界情勢

第13章 北米の分子診断市場、主要企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. North America Molecular Diagnostics Market Landscape

5. North America Molecular Diagnostics Market - Key Industry Dynamics

6. Molecular Diagnostics Market - North America Market Analysis

7. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

8. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

10. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. North America Molecular Diagnostics Market - Country Analysis

12. North America Molecular Diagnostics Market Industry Landscape

13. North America Molecular Diagnostics Market, Key Company Profiles

14. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章北米の分子診断市場情勢

第5章北米の分子診断市場-主要産業力学

第6章分子診断市場-北米市場分析

第7章北米の分子診断市場：収益と2030年までの予測 - 疾患領域別

第8章北米の分子診断市場：収益と2030年までの予測 - 技術別

第9章北米の分子診断市場：収益と2030年までの予測 - 製品・サービス別

第10章北米の分子診断市場：収益と2030年までの予測 - エンドユーザー別

第11章北米の分子診断市場：国別分析

第12章北米の分子診断市場の業界情勢

第13章北米の分子診断市場、主要企業プロファイル

第14章付録